CLINICAL_TRIALS
trial_result
· 2015-02-10
Clinical Trial Update: 12-Month Stability of Diurnal IOP Control on Cosopt [Phase 4]
Summary
Phase 4 trial assessing 12-month diurnal intraocular pressure control with Cosopt (dorzolamide/timolol) in glaucoma; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: West Virginia University | Conditions: Glaucoma | Phase 4 | Status: COMPLETED | Results posted: 2015-02-10